AbbVie Inc. (ABBV)
ABBV chart
Everything the smart money is doing in ABBV
This is the ABBV details page members see in the GTA Terminal. Previews below are blurred samples; start a free trial to see the live data.
Option Flows for ABBV
Every unusual options bet in ABBV: size, strikes, expirations and which side the money is on.
Start 14-day free trialAlready a member? Open in the Terminal →Insiders & Congress for ABBV
2 insider filings on record for ABBV. See who bought and sold, how much, and when.
Start 14-day free trialAlready a member? Open in the Terminal →Institutions for ABBV
2,254 funds added and 1,728 trimmed ABBV last quarter. See the biggest holders and their moves.
Start 14-day free trialAlready a member? Open in the Terminal →Short interest for ABBV
Short interest data for ABBV through 2026-09-30: percent of shares short, days to cover and the squeeze score.
Start 14-day free trialAlready a member? Open in the Terminal →Financials & earnings for ABBV
Eight quarters of revenue, margins and EPS for ABBV, every earnings beat and miss, and conference-call notes.
Start 14-day free trialAlready a member? Open in the Terminal →GTA AI for ABBV
Ask GTA AI for a trade idea on ABBV: bias, entry, stop and target, built from all of the data above.
Start 14-day free trialAlready a member? Open in the Terminal →Sample previews with placeholder values. Then $99/month. Cancel anytime.
Technical summary daily
| Moving average | Simple | Exponential | Signal |
|---|---|---|---|
| MA5 | 275.59 | 275.24 | Buy |
| MA10 | 269.47 | 271.75 | Buy |
| MA20 | 266.95 | 267.86 | Buy |
| MA50 | 260.13 | 260.82 | Buy |
| MA100 | 249.43 | 251.17 | Buy |
| MA200 | 233.15 | 239.23 | Buy |
| Indicator | Value | Signal |
|---|---|---|
| RSI(14) | 66.48 | Buy |
| MACD(12,26) | 4.50 | Buy |
| Stochastic(14) | 73.47 | Buy |
| ROC(12) | 4.62 | Buy |
Classic pivot points from the last full session. Technical signals are mechanical readings, not recommendations.
AbbVie Inc. news
5 High-Yield Dividend Stocks That Could Turn October’s Market Weakness Into Income24/7 Wall St. · 47 min agoPrediction: Eli Lilly Could Have More Room to Grow Than Its Valuation Suggests24/7 Wall St. · 1 hr agoAbbVie Poised for Q3 Top-Line Beat Driven by Rinvoq, Skyrizi, and Vraylar Therapies, RBC SaysMT Newswires · 1 hr agoCan a Spinoff Fix Johnson & Johnson’s Medtech Problem?Barrons.com · 1 hr agoAbbVie (ABBV) Could Be 44% Below Fair Value On Fresh Pipeline WinsSimply Wall St. · 10 hr agoAbbVie vs. Eli Lilly: Which Healthcare Stock Is a Better Buy in 2026?Motley Fool · 17 hr agoAbbVie (ABBV) Rises As Market Takes a Dip: Key FactsZacks · 20 hr agoJohnson & Johnson vs. Pfizer: Which Healthcare Stock Is a Better Buy in 2026?Motley Fool · Oct 12, 2026How do you see AbbVie Inc. today?
Results show once a few readers have voted today.
Historical data daily, last 20 sessions
| Date | Price | Open | High | Low | Vol. | Change % |
|---|---|---|---|---|---|---|
| Oct 13, 2026 | 276.57 | 283.29 | 283.32 | 275.40 | 2.12M | -1.62% |
| Oct 12, 2026 | 281.12 | 277.65 | 281.30 | 276.01 | 5.59M | +1.68% |
| Oct 09, 2026 | 276.47 | 271.53 | 277.60 | 270.38 | 4.30M | +1.49% |
| Oct 08, 2026 | 272.42 | 270.98 | 272.52 | 265.71 | 5.49M | +0.39% |
| Oct 07, 2026 | 271.36 | 268.40 | 274.94 | 266.89 | 6.08M | +1.75% |
| Oct 06, 2026 | 266.69 | 267.74 | 268.86 | 260.62 | 4.50M | +0.35% |
| Oct 05, 2026 | 265.76 | 261.27 | 267.34 | 260.29 | 7.54M | +1.12% |
| Oct 02, 2026 | 262.82 | 259.74 | 264.06 | 257.87 | 5.86M | +1.11% |
| Oct 01, 2026 | 259.93 | 260.51 | 262.32 | 259.00 | 3.89M | -0.63% |
| Sep 30, 2026 | 261.59 | 264.60 | 265.36 | 261.59 | 4.39M | -0.65% |
| Sep 29, 2026 | 263.29 | 265.45 | 268.93 | 261.52 | 4.00M | -1.12% |
| Sep 28, 2026 | 266.28 | 264.33 | 267.74 | 263.38 | 4.42M | +0.73% |
| Sep 25, 2026 | 264.34 | 265.49 | 266.00 | 262.59 | 2.54M | -0.29% |
| Sep 24, 2026 | 265.12 | 265.37 | 267.41 | 263.09 | 3.46M | +0.02% |
| Sep 23, 2026 | 265.08 | 266.00 | 269.39 | 263.59 | 3.47M | -0.05% |
| Sep 22, 2026 | 265.21 | 263.10 | 266.82 | 262.15 | 2.77M | +0.28% |
| Sep 21, 2026 | 264.48 | 263.07 | 266.60 | 261.23 | 3.43M | +0.20% |
| Sep 18, 2026 | 263.96 | 263.29 | 266.34 | 262.44 | 8.18M | -0.02% |
| Sep 17, 2026 | 264.02 | 262.61 | 264.62 | 260.88 | 3.51M | +0.58% |
| Sep 16, 2026 | 262.51 | 261.99 | 264.00 | 260.98 | 3.12M | -0.20% |
Full history, intraday charts and downloads are in the GTA Terminal.
About AbbVie Inc.
AbbVie is relentless in our pursuit to redefine the standard of care for patients living with immune-mediated conditions, with the goal of helping them live a life free from the limitations of their disease. For nearly 30 years, AbbVie has led and helped shape the field of immunology through groundbreaking science and trusted medicines. Building on deep expertise across gastroenterology, rheumatology and dermatology, and other areas of high unmet need, we continue to invest in a broad and differentiated pipeline - spanning innovative modalities, novel mechanisms of action and next-generation approaches designed to conquer the complex biology underlying immune-mediated disease. Today, more than 1 million patients worldwide are treated with AbbVie 's immunology medicines, approved in more than 175 countries across 20+ immune-mediated diseases that impact adult and pediatric populations.
People also watch
FAQ
What is the price of AbbVie Inc. today?
AbbVie Inc. (ABBV) last traded at 276.56, down 1.62% on the day.
What is the 52-week range of ABBV?
Over the past 52 weeks ABBV has traded between 190.75 and 283.31.
Is ABBV a buy or a sell?
Daily technical indicators currently read Strong Buy (10 buy vs 0 sell signals). That is a mechanical reading, not advice.
Get the GTA Daily Brief
The market's biggest stories each morning, plus what options traders, insiders and Congress are doing with their money. Free.